Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PAR PHARMACEUTICAL COS INC Financial Overview

  • Income Statement: PRX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 578.12 M 769.67 M -191.55 M -33.13%
    Gross Profit 176.57 M 268.52 M -91.95 M -52.07%
    Net Income Before Extra Items/Preferred Div -47.77 M 49.90 M -97.67 M 204.46%
    Operating Income -20.95 M 52.64 M -73.59 M 351.27%
  • Cash Flow: PRX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -50.10 M -37.67 M -12.44 M 24.82%
    Net Cash Flow - Investing 45.00 M -16.02 M 61.03 M 135.61%
    Net Cash Flow/Operating Activities 65.60 M 100.78 M -35.18 M -53.63%
  • Balance Sheet: PRX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 681.79 M 723.79 M -42.00 M -6.16%
    Total Liabilities 277.16 M 286.04 M -8.88 M -3.20%
    Shareholders Equity 404.63 M 437.76 M -33.12 M -8.19%
  • Key Ratios / Statistics: PRX

    • Valuation

      Price/Earnings (TTM) -9.38
      Price/Sales (TTM) 0.77
      Price/Book (MRQ) 1.11
      Price/Cash Flow (TTM) 8.18
    • Profitability

      Gross Margin 30.54
      Operating Margin -3.62
      Profit Margin -8.26
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.25
      Current Ratio (MRQ) 2.22
      Long Term Debt-to-Equity (MRQ) 26.32
    • Management Effectiveness

      Return on Equity (TTM) -11.63
      Return on Assets (TTM) 1.94
      Return on Investments (TTM) -7.38